Wogonin, a natural and biologically-active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T- And B-cells

In Vivo

Volumn 27, Issue 6, 2013, Pages 733-738

  Lin, Chin Chung ^a,b   Lin, Jen Jyh ^c   Wu, Ping Ping ^c   Lu, Chi Cheng ^d   Chiang, Jo Hua ^d   Kuo, Chao Lin ^c   Ji, Bin Chuan ^e   Lee, Ming Huei ^a   Huang, An Cheng ^f   Chung, Jing Gung ^c,g  

^a FENG YUAN HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f School of Medicine   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

BALB c mice; Flavonoid; Murine WEHI 3 leukemia model; Wogonin

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CELL SURFACE MARKER; FLAVONOID; PROTEIN MAC 3; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; IN VIVO STUDY; LEUKEMIA CELL; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; SURVIVAL RATE; T LYMPHOCYTE;

BALB/C MICE; FLAVONOID; MURINE WEHI-3 LEUKEMIA MODEL; WOGONIN;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVANONES; LEUKEMIA; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C;

EID: 84892745556     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. O'Neill KA, Bunch KJ and Murphy MF: Intrauterine growth and childhood leukemia and lymphoma risk. Expert Rev Hematol 5: 559-576, 2012.
2. Chen X, Zhou M, Ning B, Song H, Yang S and Tang Y: Transfusion-associated HIV infection in pediatric leukemia patients (Two Case Reports). Iran J Pediatr 22: 417-420, 2012.
3. Diamantaras AA, Dessypris N, Sergentanis TN, Ntouvelis E, Athanasiadou-Piperopoulou F, Baka M, Fragandrea I, Moschovi M, Polychronopoulou S, Stiakaki E, Panagiotakos D and Petridou E: Nutrition in early life and risk of childhood leukemia: A case control study in Greece. Cancer Causes Control 24: 117-124, 2013.
4. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL and Bertagnolli MM: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21: 921-927, 2000.
5. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, Mutoh H, Sugimura T and Wakabayashi K: Suppression by flavonoids of cyclooxygenase-2 promoterdependent transcriptional activity in colon cancer cells: Structure activity relationship. Jpn J Cancer Res 91: 686-691, 2000.
6. Wenzel U, Kuntz S, Brendel MD and Daniel H: Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60: 3823-3831, 2000.
7. Tai MC, Tsang SY, Chang LY and Xue H: Therapeutic potential of wogonin: A naturally occurring flavonoid. CNS drug reviews 11: 141-150, 2005.
8. Wakabayashi I and Yasui K: Wogonin inhibits inducible prostaglandin E(2) production in macrophages. Eur J Pharmacol 406: 477-481, 2000.
9. Lin CC, Kuo CL, Lee MH, Lai KC, Lin JP, Yang JS, Yu CS, Lu CC, Chiang JH, Chueh FS and Chung JG: Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways. Int J Oncol 39: 217- 224, 2011.
10. Yu CS, Yu FS, Chuang YC, Lu HF, Lin SY, Chiu TH and Chung JG: Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Res 25: 127-132, 2005.
11. Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH and Kong G: Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts. Int J Cancer 122: 816-822, 2008.
12. Parajuli P, Joshee N, Rimando AM, Mittal S and Yadav AK: In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med 75: 41-48, 2009.
13. Fas SC, Baumann S, Zhu JY, Giaisi M, Treiber MK, Mahlknecht U, Krammer PH and Li-Weber M: Wogonin sensitizes resistant malignant cells to TNF-α and TRAIL-induced apoptosis. Blood 108: 3700-3706, 2006.
14. Lee SO, Jeong YJ, Yu MH, Lee JW, Hwangbo MH, Kim CH and Lee IS: Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-KB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem Biophys Res Commun 351: 118-125, 2006.
15. Yang L, Zhang HW, Hu R, Yang Y, Qi Q, Lu N, Liu W, Chu YY, You QD and Guo QL: Wogonin induces G1 phase arrest through inhibiting CDK4 and cyclin D1 concomitant with an elevation in p21CIP1 in human cervical carcinoma HeLa cells. Biochem Cell Biol 87: 933-942, 2009.
16. Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, Kohler R, Giaisi M, Efferth T, Desaubry L, Krammer PH and Li-Weber M: Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of MCL-1. Cell Death Dis 2: e182, 2011.
17. Chen CC, Hung TH, Wang YH, Lin CW, Wang PY, Lee CY and Chen SF: Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-KB signaling after experimental traumatic brain injury. PLoS One 7: e30294, 2012.
18. Wang W, Guo QL, You QD, Zhang K, Yang Y, Yu J, Liu W, Zhao L, Gu HY, Hu Y, Tan Z and Wang XT: The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. Biol Pharm Bull 29: 1132-1137, 2006.
19. Baumann S, Fas SC, Giaisi M, Muller WW, Merling A, Gulow K, Edler L, Krammer PH, and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis. Blood 111: 2354-2363, 2008.
20. Lu N, Gao Y, Ling Y, Chen Y, Yang Y, Gu HY, Qi Q, Liu W, Wang XT, You QD and Guo QL: Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci 82: 956-963, 2008.
21. Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M and Shapiro CL: A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 120: 111-118, 2010.
22. Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z and Tripathy D: Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 105: 17-28, 2007.
23. Lin CC, Yu CS, Yang JS, Lu CC, Chiang JH, Lin JP, Kuo CL and Chung JG: Chrysin, a natural and biologically active flavonoid, influences a murine leukemia model in vivo through enhancing populations of T- and B-cells, and promoting macrophage phagocytosis and NK cell cytotoxicity. In Vivo 26: 665-670, 2012.
24. Yu JS and Kim AK: Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol Cells 31: 327-335, 2011.
25. Lee DH, Kim C, Zhang L and Lee YJ: Role of p53, PUMA, and BAX in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 75: 2020-2033, 2008.
26. Liu ZL, Tanaka S, Horigome H, Hirano T and Oka K: Induction of apoptosis in human lung fibroblasts and peripheral lymphocytes in vitro by Shosaiko-to derived phenolic metabolites. Biol Pharm Bull 25: 37-41, 2002.
27. Lee WR, Shen SC, Lin HY, Hou WC, Yang LL and Chen YC: Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem Pharmacol 63: 225-236, 2002.
28. Sato S, Jansen PJ and Tedder TF: CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B-lymphocyte signaling. Proc Natl Acad Sci USA 94: 13158-13162, 1997.
29. Kwon SH, Nam JI, Kim SH, Kim JH, Yoon JH and Kim KS: Kaempferol and quercetin, essential ingredients in Ginkgo bilboa extract, inhibit interleukin-1β-induced MUC5AC gene expression in human airway epithelial cells. Phytother Res 23: 1708-1712, 2009.